Drug Trial Radar · NCT06523959
Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial
Last checked: Nov 20, 2026Latest source record: May 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
5,436
Planned (sponsor's estimate)
Start
Jun 6, 2024
Primary completion
Sep 30, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Clinical Urology and Epidemiology Working GroupGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- Collaborators
- Helsinki University Central Hospital; University of Helsinki; University College, London; Population Health Research Institute; Tabriz University of Medical Sciences; Tampere University Hospital; Turku University Hospital; Oulu University Hospital; North Karelia Central Hospital; Albany Medical College; PaijatHame Central Hospital
- First posted
- Jul 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Avoiding Risks of Thrombosis and bleeding in Surgery (ARTS) trial is a pragmatic, international, multicenter, randomized controlled open label trial comparing a direct oral anticoagulant (DOAC) - oral factor Xa inhibitor apixaban - to no anticoagulant among 5,436 patients undergoing abdominal or pelvic surgery at sufficiently similar (and not high) risk of venous thromboembolism (VTE) and bleeding that the net impact - benefit or harm - of thromboprophylaxis remains in doubt.
Conditions
- Venous Thromboembolism
- Bleeding
Interventions
Apixaban 2.5 MGDrug
To evaluate the benefits and risks of thromboprophylaxis with oral factor Xa inhibitor Apixaban compared to No anticoagulation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence composite outcome of venous thromboembolism (VTE)Time frame: 90 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Helsinki University Hospital
Helsinki, Finland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.